CIBC Private Wealth Group
IMCR icon

CIBC Private Wealth Group’s Immunocore IMCR Stock Holding History

CIBC Private Wealth Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.74K Sell
223
-127
-36% -$4.48K ﹤0.01% 2502
2025
Q3 		$12.7K Sell
350
-16
-4% -$544 ﹤0.01% 2308
2025
Q2 		$11.5K Buy
366
+9
+3% +$280 ﹤0.01% 2200
2025
Q1 		$8.76K Buy
357
+7
+2% +$210 ﹤0.01% 2278
2024
Q4 		$10.6K Sell
350
-150
-30% -$4.74K ﹤0.01% 2247
2024
Q3 		$15.6K Hold
500
– – ﹤0.01% 2262
2024
Q2 		$18.7K Hold
500
– – ﹤0.01% 2051
2024
Q1 		$31.5K Buy
+500
New +$34.3K ﹤0.01% 1858

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CIBC Private Wealth Group's IMCR Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Immunocore (IMCR) stake by 36% in Q4 2025, selling an estimated $4.48K and leaving 223 shares worth $7.74K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

CIBC Private Wealth Group first reported a position in IMCR in Q1 2024 and has held it in 8 quarters since. The position peaked at $31.5K in Q1 2024. 149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

  • CIBC Private Wealth Group held 223 shares of Immunocore worth $7.74K as of Q4 2025.
  • CIBC Private Wealth Group sold 127 Immunocore shares in Q4 2025, an estimated $4.48K.
  • Immunocore made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2502 holding.
  • CIBC Private Wealth Group first reported a position in Immunocore in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Immunocore position peaked at $31.5K in Q1 2024.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.